Crystalline pharmaceutical and methods of preparation and use thereof
1. A composition comprising an isolated compound of Formula I:
Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention.
- 1. A composition comprising an isolated compound of Formula I: